GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerSep 30Weekly roundup, 8 itemsgepotidacinGlaxoSmithKlineUpdated
GSK's IPF drug GSK3915393 fails Phase 2 on futility; expanded access opens for velzatinib in GISTSep 18Weekly roundup, 2 itemsGlaxoSmithKlineGSK3915393
GSK posts bepirovirsen QT results; registers Mo-Rez ovarian, endometrial Phase 3 trialsJul 10Weekly roundup, 6 itemsbepirovirsencamlipixant
Sign inSign in